XML 153 R89.htm IDEA: XBRL DOCUMENT
v3.24.0.1

COMMITMENTS AND CONTINGENCIES (Details) $ in Thousands | Oct. 23, 2023 USD ($) installment | Aug. 03, 2023 USD ($) | Dec. 21, 2020 patent | Dec. 31, 2023 USD ($)
--- | --- | --- | --- | ---
Myriad Genetics, Inc. Securities Litigation |  |  |  |
Loss Contingencies [Line Items] |  |  |  |
Settlement agreement |  | $ 77,500 |  |
Raygen, Inc Versus Myriad Women's Health, Inc. |  |  |  |
Loss Contingencies [Line Items] |  |  |  |
Number of patents allegedly infringed | patent |  |  | 2 |
Accrual |  |  |  | $ 29,000
Accrual, noncurrent |  |  |  | 24,000
Accrual, current |  |  |  | $ 5,000
Raygen, Inc Versus Myriad Women's Health, Inc. | Settled Litigation, Non-Contingent Payments |  |  |  |
Loss Contingencies [Line Items] |  |  |  |
Settlement agreement | $ 12,750 |  |  |
Number of annual installments | installment | 3 |  |  |
Raygen, Inc Versus Myriad Women's Health, Inc. | Settled Litigation, Contingent Payments |  |  |  |
Loss Contingencies [Line Items] |  |  |  |
Settlement agreement | $ 21,250 |  |  |
Number of annual installments | installment | 5 |  |  |
Raygen, Inc Versus Myriad Women's Health, Inc. | First Installment | Settled Litigation, Non-Contingent Payments |  |  |  |
Loss Contingencies [Line Items] |  |  |  |
Settlement agreement | $ 5,000 |  |  |
Raygen, Inc Versus Myriad Women's Health, Inc. | First Installment | Settled Litigation, Contingent Payments |  |  |  |
Loss Contingencies [Line Items] |  |  |  |
Settlement agreement | 5,000 |  |  |
Raygen, Inc Versus Myriad Women's Health, Inc. | Second Installment | Settled Litigation, Non-Contingent Payments |  |  |  |
Loss Contingencies [Line Items] |  |  |  |
Settlement agreement | 5,000 |  |  |
Raygen, Inc Versus Myriad Women's Health, Inc. | Second Installment | Settled Litigation, Contingent Payments |  |  |  |
Loss Contingencies [Line Items] |  |  |  |
Settlement agreement | 5,000 |  |  |
Raygen, Inc Versus Myriad Women's Health, Inc. | Third Installment | Settled Litigation, Non-Contingent Payments |  |  |  |
Loss Contingencies [Line Items] |  |  |  |
Settlement agreement | 2,750 |  |  |
Raygen, Inc Versus Myriad Women's Health, Inc. | Third Installment | Settled Litigation, Contingent Payments |  |  |  |
Loss Contingencies [Line Items] |  |  |  |
Settlement agreement | 5,000 |  |  |
Raygen, Inc Versus Myriad Women's Health, Inc. | Fourth Installment | Settled Litigation, Contingent Payments |  |  |  |
Loss Contingencies [Line Items] |  |  |  |
Settlement agreement | 5,000 |  |  |
Raygen, Inc Versus Myriad Women's Health, Inc. | Fifth Installment | Settled Litigation, Contingent Payments |  |  |  |
Loss Contingencies [Line Items] |  |  |  |
Settlement agreement | $ 1,250 |  |  |

X
- Definition Litigation Settlement, Number Of Installments + References No definition available. + Details
Name: | mygn_LitigationSettlementNumberOfInstallments
Namespace Prefix: | mygn_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount awarded to other party in judgment or settlement of litigation. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementAmountAwardedToOtherParty
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9 + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of loss contingency liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1 Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-10 + Details
Name: | us-gaap_LossContingencyAccrualAtCarryingValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1 + Details
Name: | us-gaap_LossContingencyAccrualCarryingValueCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1 + Details
Name: | us-gaap_LossContingencyAccrualCarryingValueNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of another entity's patents that the entity has allegedly infringed. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9 + Details
Name: | us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_LitigationCaseAxis=mygn_MyriadGeneticsIncSecuritiesLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=mygn_RaygenIncVersusMyriadWomensHealthIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=mygn_SettledLitigationNonContingentPaymentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=mygn_SettledLitigationContingentPaymentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | mygn_LitigationInstallmentsAxis=mygn_FirstInstallmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | mygn_LitigationInstallmentsAxis=mygn_SecondInstallmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | mygn_LitigationInstallmentsAxis=mygn_ThirdInstallmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | mygn_LitigationInstallmentsAxis=mygn_FourthInstallmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | mygn_LitigationInstallmentsAxis=mygn_FifthInstallmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |